Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger CCCH domain-containing protein 3 (ZC3H3) is a member of the CCCH-type zinc finger family, characterized by its specific zinc finger motif configuration which typically confers RNA binding activity rather than classical DNA binding. ZC3H3 is required for the export of polyadenylated mRNAs from the nucleus and enhances SMAD-mediated transcriptional responses, particularly downstream of activin receptor signaling. It is localized in the nucleus and participates in mRNA 3'-end processing, mRNA transport, and likely in the regulation of specific aspects of RNA metabolism. The protein can bind single-stranded DNA but not double-stranded DNA in vitro, and is predicted to be involved in RNA cleavage. Although no direct roles in specific diseases or as a therapeutic target have been established, the related CCCH-type zinc finger family is implicated in regulating inflammation, immunity, and viral processes through effects on RNA stability and processing.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger CCCH domain-containing protein 3 (ZC3H3).